Matches in Nanopublications for { ?s ?p "[The promoter methylation of TIMP-3 was significantly higher in adenocarcinoma than in squamous cell carcinoma (41.7% vs 3%, respectively, P= 0.0175).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- NP485422.RAwu8YZFxH6xl-hc9im8FS-_TByFw2EORNj6g51hgYlcQ130_assertion description "[The promoter methylation of TIMP-3 was significantly higher in adenocarcinoma than in squamous cell carcinoma (41.7% vs 3%, respectively, P= 0.0175).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP485422.RAwu8YZFxH6xl-hc9im8FS-_TByFw2EORNj6g51hgYlcQ130_provenance.
- NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_assertion description "[The promoter methylation of TIMP-3 was significantly higher in adenocarcinoma than in squamous cell carcinoma (41.7% vs 3%, respectively, P= 0.0175).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427526.RAr36Hzv57X0nB0BCUwtT2A7cKp6_CGlyA-JctgmpFymo130_provenance.
- NP512724.RA0sF5bCTbjASbKZyypUjuXpdvni8WWNVR4UevfFDaF-4130_assertion description "[The promoter methylation of TIMP-3 was significantly higher in adenocarcinoma than in squamous cell carcinoma (41.7% vs 3%, respectively, P= 0.0175).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP512724.RA0sF5bCTbjASbKZyypUjuXpdvni8WWNVR4UevfFDaF-4130_provenance.
- NP556715.RACN4v-nnkz_w1Gl2Cs6gNPf2_O8FfAuFlSj8JcPYpSac130_assertion description "[The promoter methylation of TIMP-3 was significantly higher in adenocarcinoma than in squamous cell carcinoma (41.7% vs 3%, respectively, P= 0.0175).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556715.RACN4v-nnkz_w1Gl2Cs6gNPf2_O8FfAuFlSj8JcPYpSac130_provenance.
- NP738646.RAoVn6atA066K2A9UI25rQ0bmRtASHtKlw-gogrHcXAvE130_assertion description "[The promoter methylation of TIMP-3 was significantly higher in adenocarcinoma than in squamous cell carcinoma (41.7% vs 3%, respectively, P= 0.0175).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738646.RAoVn6atA066K2A9UI25rQ0bmRtASHtKlw-gogrHcXAvE130_provenance.
- NP738713.RANN2zKwtBZMXVrS_Z4Se_MadRE7u_ZJ_f8X0PZRHNuXA130_assertion description "[The promoter methylation of TIMP-3 was significantly higher in adenocarcinoma than in squamous cell carcinoma (41.7% vs 3%, respectively, P= 0.0175).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP738713.RANN2zKwtBZMXVrS_Z4Se_MadRE7u_ZJ_f8X0PZRHNuXA130_provenance.
- NP556716.RA1cLEPrpZdphkRMLt42CH-p7rm15iYGIIH3cPn-svNys130_assertion description "[The promoter methylation of TIMP-3 was significantly higher in adenocarcinoma than in squamous cell carcinoma (41.7% vs 3%, respectively, P= 0.0175).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP556716.RA1cLEPrpZdphkRMLt42CH-p7rm15iYGIIH3cPn-svNys130_provenance.